Clinical Trial Update: A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing pharmacokinetics and safety of PA-111 and PA-111A in adults with mixed dyslipidemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• PA-111
• PA-111A

Snippet

Sponsor: Addpharma Inc. | Conditions: Mixed Dyslipidemia | Phase 1 | Status: RECRUITING